Osteotome-mediated sinus floor elevation: a clinical report

PURPOSE: It was the aim of the present study to clinically evaluate the success of osteotome-mediated sinus floor elevation (OMSFE) using autogenous and xenogenic bone and a variety of screw-type implants. MATERIALS AND METHODS: From August 1995 to February 2003, 276 OMSFE procedures with simultaneous implant placement were completed in 167 patients. RESULTS: The mean residual bone height (RBH) of the alveolar ridge was 7.1 mm (range 3 to 10 mm). The mean increase in height of the implant sites using osteotome techniques was 3.8 mm (range 2 to 7 mm). Of the 276 implants placed, 240 had been loaded for an average of 27.9 months (range 1 to 84 months). There were a total of 18 failures: Ten implants failed to integrate, 3 implants were lost within the first 18 months of loading, 1 implant fractured after 3 years in function, and 4 implants demonstrated excessive bone loss. The overall survival rate was 93.5%. When only sites with an RBH of 4 mm or less were considered, the survival rate dropped to 73.3%. Small tears in the schneiderian membrane were clinically assessed at 13 sites, for a detectable perforation rate of 4.7%. DISCUSSION: The primary determinant in implant survival with OMSFE procedures was the height of the residual alveolar ridge. Implant design, graft material, and the method of sinus floor infracture (direct or bone-cushioned) exerted minimal influence on survival outcome; however, factors such as edentulism, osteoporosis, and an overdenture prosthesis were shown to negatively influence postloading survival of implants placed in areas of limited RBH. CONCLUSION: OMSFE procedures can be used predictably for implant placement at sites with moderate vertical deficiencies in the posterior maxilla.     

Maxillary sinus floor elevation combined with a vertical onlay graft

We performed maxillary sinus floor elevation combined with a vertical onlay graft for a total of 11 sides of nine patients (1 woman and 8 men) in our Hospital. On CT, the preoperative minimum alveolar bone thickness with a mean of 1.8 mm was improved to 15.3 mm within a month after this surgery. A total of 20 dental implants were placed and there was only one failed implant. With the average follow-up of 15.6 months, an average of 3.4 mm of bone absorption was found in the site of the maxillary sinus and 1.1 mm in the site of the onlay graft. The crown-implant ratio in all cases was within the permissible range. Consequently, this bone augmentation surgery was considered to be useful.     

Evaluation of sinus floor elevation using a composite bone graft mixture

BACKGROUND: The performance of implant surgery in the posterior maxilla often poses a challenge due to insufficient available bone. Sinus floor elevation was developed to increase needed vertical height to overcome this problem. The present study described and reported a simple, safe and predictable bone graft mixture for the sinus lifting procedure. MATERIAL AND METHODS: Seventy patients were recruited for this study and underwent a sinus lift procedure. All sites were treated with a composite graft of cortical autogenous bone, bovine bone and platelet-rich plasma (PRP). A total of 263 implants (171 Astra Tech and 92 Microdent) were placed either simultaneously or delayed. All sites were clinically and radiographically evaluated 24 months after their prosthetic loading. Biopsy samples were taken from 16 delayed implant placement sites at the time of their implant placement. RESULTS: A 100% implant success rate was found after 24 months of functioning. Only two Microdent implants failed before loading, which translates to a 99% overall implant success rate. No statistically significant differences were found between simultaneous and delayed implant placement. Image processing revealed 34+/-6.34% vital bone, 49.6+/-6.04% connective tissue and 16.4+/-3.23% remaining Bio-Oss particles. However, the histomorphometric analysis showed that the bovine bone was incorporated into new bone formation. CONCLUSION: The results showed that a composite graft comprised of cortical autogenous bone, bovine bone and PRP mixture can be successfully used for sinus augmentation.     

不做窦底骨移植上颌窦内提升术2年疗效观察

目的:研究不做骨移植的上颌窦内提升术(osteotome sinus floor elevation,OSFE)后的牙种植体留存率及周围骨组织变化规律.探讨种植体突人上颌窦内(≤3mm)病例中种植体周围有无新骨形成及其稳定性.方法:23例单个上颌后牙缺失患者,种植区剩余垂直骨高度(residual bone high,RBH)为5～8mm,接受OSFE+牙种植体植入术,控制种植体突入上颌窦内长度≤3mm,植入后3～4个月行种植体上部结构永久修复.通过牙种植体植入后2a连续临床观察,分析种植体留存率;通过X线测量(手术后及植入后3、6、12、24个月),观察种植体突入上颌窦内的长度变化及成骨规律.结果:2a种植体留存率为100%;X线测量显示,种植体突入上颌窦内部分,其近远中侧有成骨现象且2a内保持稳定.结论:在适当病例中进行不做窦底骨移植的OSFE是可行的.     

保留上颌窦假性囊肿穿牙槽嵴顶入路上颌窦底提升的临床研究

目的:评估在保留上颌窦假性囊肿的条件下,进行穿牙槽嵴顶入路的上颌窦底提升的临床效果。方法:14例患者接受保留上颌窦假性囊肿的穿牙槽嵴顶入路上颌窦底提升术,同期植入种植体,共植入15枚种植体。分别在术前、术后即刻和术后1年拍摄CBCT,测量植骨区骨量变化及上颌窦假性囊肿变化。结果:全部手术中无囊肿破裂和上颌窦黏膜穿孔,愈合期种植体骨结合良好,随访期无种植体脱落。术前上颌窦底剩余骨高度为(6.85±1.07)mm.术中提升高度为(6.93±2.07)mm。术后窦底提升高度(GBH)为(13.88±1.87)mm、1年后骨愈合后窦嵴距(GSH-1)(12.76±2.03)mm。随访期内,囊肿增大3例,基本不变3例,减小5例,消失3例。结论:上颌窦底提升术的同时保留上颌窦假性囊肿可获得较满意疗效。     

几种植骨材料在外提升术骨高度改建的临床远期观察

目的：观察比较不同植骨材料在外提升植骨垂直骨高度的远期改建情况。方法：选择行外提升57例患者,随即分为三组,第一组植骨材料为100%Bio-Oss骨粉;第二组植骨材料为100%beta-TCP骨粉;第三组植骨材料为50%Bio-Oss混合50%beta-TCP骨粉。每个患者进行5次以上的全景片检查,其中三张进行定点定量检测。第一磨牙种植体的远中骨高度为L1,第一磨牙与第二磨牙种植体之间骨高度为L2,第二磨牙种植体远中5mm处的骨高度为L3。检测和比较垂直向骨高度的变化。结果：经60-84个月的临床追踪观察,每组L1,L2与L3垂直向骨高度改变无统计学意义的显著差异;100%Bio-Oss组与50%Bio-Oss＋50%beta-TCP组比较,骨高度无统计学差异,但100%Bio-Oss组与100%beta-TCP组比较,骨高度改变有统计学差异.结论：初始18个月,外提升骨垂直向高度改建较明显,18个月后骨高度变化较小,100%beta-TCP组与100%Bio-Oss组比较骨吸收明显。     

Maxillary sinus floor elevation and grafting with deproteinized bovine bone mineral: a clinical and histomorphometric study

Objectives: This study evaluated the histomorphometric and clinical outcomes of maxillary sinus floor elevation using deproteinized bovine bone mineral (DBBM). Material and methods: Maxillary sinuses with a residual vertical height of <5 mm were augmented with DBBM alone before implant placement 9 months later. At the time of implant surgery, trephine samples were removed and histological and histomorphometric analyses were performed to examine the percentage of bone and residual graft using point counting and software‐aided analysis. Patients were recalled for clinical and radiographic examination up to 3 years later. Results: Twenty‐five patient specimens were analysed. The percentages of regenerated bone and residual graft material were 19% and 40%, respectively. Software‐aided analysis was comparable to point counting. Twelve patients attended for clinical follow‐up. Implants placed into this regenerated bone exhibited success and survival rates of 100% after an average follow‐up of 3 years. The average vertical height gained was 7.9 mm. Conclusions: The use of DBBM alone in maxillary sinus floor elevation is a predictable method to gain vertical bone height in the posterior maxilla. To cite this article :
Lee DZ, Chen ST, Darby IB. Maxillary sinus floor elevation and grafting with deproteinized bovine bone mineral: a clinical and histomorphometric study.
Clin. Oral Impl. Res. 23 , 2012; 918–924
doi: 10.1111/j.1600‐0501.2011.02239.x     

The endoscopically controlled osteotome sinus floor elevation: a preliminary prospective study

PURPOSE: It was the aim of the present prospective study to quantify the gain in height of implant sites by endoscopically controlled osteotome sinus floor elevations (ECOSFE) with simultaneous implant placement and to report the number of sinus membrane perforations. MATERIALS AND METHODS: From October 1999 to December 2000, of 92 sinus floor elevations, 18 were carried out endoscopically controlled with an osteotome technique. As augmentation material, beta-tricalcium phosphate (beta-TCP) or autogenous bone was used; 22 implants were placed. RESULTS: The residual height of the alveolar crest in the posterior maxilla was 6.8 +/- 1.6 mm on average. The implant lengths ranged from 10 to 16 mm (mean implant length 12.2 +/- 1.4 mm). They were significantly larger than the residual height of the alveolar crests (P < .0005). Elevation of the sinus floor with an osteotome had to be supported by conventional sinus floor elevation instruments after a mean elevation of 3.0 +/- 0.8 mm to prevent perforation of the sinus membrane. However, 1 perforation occurred, which was repaired with a periosteal patch. At stage 2 surgery, 2 implants were removed because of mobility. Endoscopic control revealed one case in which beta-TCP could be found within the sinus; another case showed areas of polypoid mucosa on the sinus floor. DISCUSSION: With the ECOSFE, perforations of the sinus membrane can be visualized; however, they cannot be avoided. Although this technique is less invasive than the lateral window technique, it cannot be recommended as a standard procedure in the posterior maxilla because of the large amount of additional equipment needed and the technically demanding procedure. CONCLUSION: The use of the ECOSFE should be confined to scientific trials.     

Osteotome sinus floor elevation with or without grafting: a preliminary clinical trial

Objectives: This clinical trial aimed (1) to evaluate the predictability of the osteotome sinus floor elevation (OSFE) technique, (2) to study the influence of simultaneous grafting on the clinical success of placing dental implants in the posterior maxilla using OSFE and (3) to observe the bone changes in the elevated space with OSFE without grafting. Material and methods: Two hundred and eighty Straumann^® implants were placed in the posterior maxillae of 202 patients using OSFE. One hundred and ninety‐one implants were placed in 125 patients without grafting. The implants were allowed to heal for 3–4 months for non‐grafted implants and for 6–8 months for grafted cases. For radiographic analyses, periapical and panoramic radiographs were taken of 30 implants at 3 and 9 months to assess the bone changes for the elevated sites without grafting. Results: Two hundred and sixty‐eight of 280 implants fulfilling the survival criteria represented a cumulative survival rate of 95.71%. The residual bone height (RBH) was 5.6±2.5 mm for the non‐grafted group and 4.7±2.1 mm for the grafted group. The perforation rate was 4.29%. No significant differences were found between the two groups in RBH, survival rate or membrane perforation rate. The radiographic analyses demonstrated that new bone formation in the elevated sinus was visible and the endo‐sinus bone gain was 2.26±0.92 mm and 2.66±0.87 mm at 3‐ and 9‐ month follow‐up, respectively. Crestal bone loss (CBL) was 0.89±0.5 and 1.2±0.48 mm at 3 and 9 months. For the two test groups, RBH did not have a significant influence on the survival of the implants. At the 9‐month follow‐up, the endo‐sinus bone gain and CBL were not significantly correlated to RBH. The implant protrusion length was significantly correlated to the endo‐sinus bone gain. Conclusions: The findings of this study indicated that uneventful osseointegration may be predictable on applying OSFE whether with or without grafting in atrophic posterior maxilla. Spontaneous new bone formation seemed to be expected with implants placed using OSFE without simultaneous grafting. To cite this article:
Lai H‐C, Zhuang L‐F, Lv X‐F, Zhang Z‐Y, Zhang Y‐X, Zhang Z‐Y. Osteotome sinus floor elevation with or without grafting: a preliminary clinical trial.
Clin. Oral Impl. Res. 21 , 2010; 520–526.
doi: 10.1111/j.1600‐0501.2009.01889.x     

Maxillary sinus floor elevation surgery. A clinical,radiographic and endoscopic evaluation

Although augmentation of the maxillary sinus floor with autogenous bone grafts has become a well established preimplantology procedure, its effect on the function of the maxillary sinus has not been the subject of prospective human studies. In this prospective study the effects of sinus floor augmentation on maxillary sinus performance were evaluated. Seventeen consecutive patients who were to undergo augmentation of the maxillary sinus floor with an iliac crest autogenous bone graft agreed to participate in this study. All patients were subject to (i) extensive anamnestic and clinical investigation on sinusitis, (ii) conventional radiography (Waters' projection) and (iii) unilateral endoscopic inspection of the maxillary sinus. This triad of evaluations was performed preoperatively, immediately preceding the augmentation procedure (the maxillary sinus to be inspected endoscopically was randomly selected), and at 3 (at insertion of the implants) and 9 months (at uncovering of implants) postaugmentation. None of the 17 patients showed clinical or radiological signs of actual sinus pathology preoperatively, though 5 patients had a history of an impeded sinus clearance. By contrast, unilateral endoscopic evaluation revealed pre-existing subclinical mucosal pathology in two out of five patients with a history of sinus clearance impairment and in one out of the other 12 patients. At 3 months' postaugmentation, clinical and radiographical examination showed chronic maxillary sinusitis in one non-compromised patient. Moreover, serial unilateral endoscopic evaluation revealed subclinical maxillary mucosal pathology in four other patients (two of whom had a history of an impeded sinus clearance), confirmed by Waters' projection in three of these four patients. At 9 months' postaugmentation, only subclinical maxillary mucosal pathology was detected endoscopically in two patients (one compromised, one non-compromised patient), confirmed by Waters' projection in this last patient. Five implants were lost during the 9-month observation period. As is obvious from this prospective evaluation, the effects of the augmentation procedure on maxillary sinus performance in patients without signs of maxillary sinusitis are of no clinical significance.     

冲压式上颌窦底提升术同期种植临床分析

目的:探讨上颌后牙区采用冲压式上颌窦底提升术植骨与不植骨同期种植的效果。方法:2001年1月—2007年12月,共完成冲压式上颌窦底提升种植修复病例91例,男35例,女56例,随机分为2组,植骨组47例,植入57颗种植体;不植骨组44例,植入种植体51颗,共植入108颗种植体。上颌窦底剩余牙槽骨高度为5～11mm,提升幅度为2～6mm。平均随访56.8个月。35例患者(41颗种植体)于后期随访中行锥形束CT(CBCT)和根尖片,观察种植体新骨形成量和种植体突出窦底高度,应用SPSS17.0软件包对数据进行方差分析和t检验。结果:植骨组7颗种植体脱落,存留率为87.7%;不植骨组3颗种植体脱落,存留率为94.1%。CBCT扫描显示,提升幅度为2～4mm时,植骨组新骨形成高度为(2.7±1.3)mm,不植骨组为(2.4±1.5)mm,2组间无统计学差异;提升幅度为4～6mm时,植骨组新骨形成高度为(3.5±1.3)mm,不植骨组为(1.3±0.4)mm,植骨组比不植骨组新骨形成高度显著增加。结论:在上颌后牙缺失区采用冲压式上颌窦底提升、不植骨同期种植是安全可行的,植骨材料对于促进新骨形成并非必须,然而提升幅度较大时,植骨能获得更多的骨量。     

Transcrestal sinus floor elevation: report of a case series

The technique of the osteotome-mediated transcrestal sinus floor elevation is described in a series of case reports. Fifty-five patients received a total of 66 implants over a period of 6 years. Bio-Oss was added in more than 60% of cases to increase the stability of the lifted area. The surgical procedure appeared to be a safe method that was well supported by the patients. It was applied for different prosthetic indications in partially and completely edentulous situations. The survival rate of the implants during the healing phase was 98.5%, and it was 100% after loading. The patients' responses to the Summers technique were evaluated by means of short interviews and visual analog scales (VAS), and the answers were compared with those from a group of patients who had received implants in the same location during the same period but without the osteotome technique. The answers regarding pain were not different between the groups. However, significantly more patients who had received the implants by means of the osteotome technique judged the surgical procedure as highly uncomfortable. It is concluded that patients need to be well prepared for the procedure.     

Early healing after elevation of the maxillary sinus floor applying a lateral access: a histological study in monkeys

Aim: To describe the early healing within the void obtained after the elevation of the sinus mucosa and simultaneous implant installation without the use of any grafting material in monkeys. Material and methods: Implants were installed simultaneously with the elevation of the maxillary sinus using the lateral approach in eight monkeys without the use of grafting material. The healing after 4, 10, 20 and 30 days was evaluated in the area distal to the implants. Paraffin sections were prepared and analyzed using qualitative histological methods. Results: The healing process was initiated by the formation of a coagulum and followed by a provisional matrix and woven bone. Subsequently, a parallel‐fiber bone replaced woven bone. The dimension of the elevated area shrank during the healing process. Sprouts of woven bone, present to a moderate extent after 4 days, were more numerous after 10 and 20 days. Newly formed bone originated from the sinus walls and septa, while there was no evidence of participation of the Schneiderian membrane in this process. After 30 days, the window access appeared to be closed by a layer of newly formed trabecular bone. Conclusions: The coagulum that filled the void distal to the implant after simultaneous elevation of the sinus floor gave rise to newly formed bone. However, the void occupied by the coagulum shrank substantially. The Schneiderian membrane did not provide a basis for new bone formation in the early phase of healing. To cite this article:
Scala A, Botticelli D, Rangel IG Jr, de Oliveira JA, Okamoto R, Lang NP. Early healing after elevation of the maxillary sinus floor applying a lateral access: a histological study in monkeys.
Clin. Oral Impl. Res. 21 , 2010; 1320–1326.
doi: 10.1111/j.1600‐0501.2009.01964.x     

用盘钻经牙槽嵴提升上颌窦底手术的临床效果观察

目的 观察并评估应用盘钻行经牙槽嵴上颌窦底提升同期种植体植入术的临床效果.方法 上颌后牙缺失患者37例,种植区剩余牙槽骨高度为3～8 mm,平均(5.61±1.61) mm,应用盘钻行上颌窦底提升,同期植入种植体51枚,评估手术安全性及舒适度.术后3～6个月行上部结构修复,随访3～24 个月,观察种植体稳定性、骨结合及种植体周围骨量变化情况.结果 本组术中提升上颌窦底高度2～8 mm,平均(4.75±1.55) mm;所有病例均未发生上颌窦黏膜穿孔,患者主观感觉良好,痛苦指数为(2.22±0.98).随访期内,所有病例均未出现上颌窦感染等并发症,骨结合良好,种植体及修复体无松动、脱落,留存率100%.种植体根方骨量于术后6个月趋于稳定,术后1年颈部骨吸收(1.20±0.72) mm.结论 应用盘钻行经牙槽嵴上颌窦底提升同期种植体植入术,近期效果满意.

Abstract：

Objective To evaluate the clinical effect of the disk-up sinus reamer (DSR) applied to transcrestal maxillary sinus floor elevation with simultaneous placement of implants. Methods Thirty-seven patients underwent transcrestal maxillary sinus floor elevation with fifty-one implants placed simultaneously using the DSR. The residual bone height(RBH) was 3 to 8 mm, (5.61±1.61) mm on average. The safety of this technique and the pain index during the operation was evaluated. The final prostheses were restored in 3-6 months postoperatively. The follow-up period was 3 to 24 months. The stability and osseointegration of the implants were clinically evaluated, and the endo-sinus bone gain around the implants were measured. Results The elevation height ranged from 2 to 8 mm, with an average of (4.75±1.55) mm. There was no detectable sinus membrane perforation, no serious suffering or uncomfortable subjective sensation in any patients during operation with a pain index of (2.22±0.98). During the follow-up period, no sinus complication was observed. Favorable osseointegration was obtained. There were no implants or prostheses which were loose or lost. The survival rate was 100%. The radiographic results demonstrated that the endo-sinus bone gain tended to reach stabilization after 6 months and the marginal bone loss was(1.20±0.72) mm after 12 months. Conclusions Transcrestal maxillary sinus floor elevation with simultaneous implant placement by DSR is a safe, invasive and handy technique, with higher elevation height,fewer clinical complications and less pain. It shows satisfactory clinical results in short term and a long-term observation is still needed.     

The incidence of maxillary sinus membrane perforation during endoscopically assessed crestal sinus floor elevation: a pilot study

Transcrestal sinus membrane elevation is a surgical procedure performed to increase the bone volume in the maxillary sinus cavity. Because of visual limitations, the potential for maxillary sinus membrane perforations may be greater than with the lateral approach technique. The aim of this study was to macroscopically investigate ex vivo the occurrence of sinus membrane perforation during surgery using 3 transcrestal sinus floor elevation methods. Twenty fresh human cadaver heads, with 40 intact sinuses, were used for simultaneous sinus membrane elevation, placement of graft material, and dental implants. Real-time sinus endoscopy, periapical digital radiographs, and cone-beam computerized tomography (CBCT) images were subsequently used to evaluate the outcome of each surgical procedure. Perforation rates for each of the 3 techniques were then compared using a significance level of P < .05. No statistically significant differences in the perforation rate (P = .79) were found among the 3 surgical techniques. Although the sinus endoscope noted a higher frequency of perforations at the time of implant placement as compared with instrumentation or graft insertion, the difference was not statistically significant (P = .04). The CBCT readings were judged to be more accurate for identifying evidence of sinus perforations than the periapical radiographs when compared with the direct visualization with the endoscope. This pilot study demonstrated that a sinus membrane perforation can occur at any time during the sinus lift procedure, independent of the surgical method used.